Familial Nasopharyngeal Carcinoma 6

More documents

Recommendations

Info

334 List of ContributorsIvan W.K. Tham, MDDepartment of Radiation OncologyNational University Cancer InstituteNational University Health SystemNational University of Singapore5 Lower Kent Ridge RoadSingapore 119074Republic of SingaporeEugene Yu, MD, FRCPCDepartment if Medical ImagingPrincess Margaret Hospital610 University AvenueToronto, ON M5G 2M9CanadaEmail: Eugene.yu@.uhn.on.caJoseph Wee, MD, FRCRDuke-NUS Graduate Medical School8 College RoadSingapore 169857Republic of Singapore.Department of Radiation OncologyDivision of Clinical Trials and Epidemiological SciencesThe Humphrey Oei Institute of Cancer ResearchNational Cancer Center11 Hospital DriveSingapore 169610Republic of SingaporeEmail: trdwts@nccs.com.sgWilliam I. Wei, MS FRCS, FRCSE, FRACS(Hon), FACS,FHKAM(Surg)(ORL)The University of Hong Kong,Queen Mary HospitalThe University of Hong KongPok Fu Lam RoadHong Kong SARP.R. ChinaEmail: hrmswwi@hkucc.hku.hkMu-Sheng Zeng, PhD, MDState Key Laboratory of Oncology in Southern ChinaCancer Center of Sun Yat-sen University651 East Dongfeng RoadGuangzhou, Guangdong 510060P.R. ChinaEmail: zengmsh@mail.sysu.edu.cnYi-Xin Zeng, MDCancer Center of Sun Yat-sen University651 East Dongfeng RoadGuangzhou, Guangdong 510060P.R. ChinaEmail: zengyix@mail.sysu.edu.cn
Page 2:
MEDICAL RADIOLOGYRadiation Oncology
Page 6:
Jiade J. Lu, MD, MBAAssociate Profe
Page 10:
PrefaceNasopharyngeal cancer is a u
Page 14:
Contents1 The Epidemiology of Nasop
Page 18:
The Epidemiology of Nasopharyngeal
Page 22:
Page 26:
Page 30:
Page 34:
10 M-S. Zeng and Y-X. Zengenvironme
Page 38:
12 M-S. Zeng and Y-X. Zengmedicinal
Page 42:
14 M-S. Zeng and Y-X. Zengloss and
Page 46:
16 M-S. Zeng and Y-X. ZengNPC sampl
Page 50:
18 M-S. Zeng and Y-X. Zengthe basal
Page 54:
20 M-S. Zeng and Y-X. Zengmultistep
Page 58:
22 M-S. Zeng and Y-X. ZengHui AB, L
Page 62:
24 M-S. Zeng and Y-X. ZengSnudden D
Page 66:
Molecular Signaling Pathways 3in Na
Page 70:
Molecular Signaling Pathways in Nas
Page 74:
Page 78:
Page 82:
Page 86:
Page 90:
Page 94:
Natural History, Presenting Symptom
Page 98:
Page 102:
Page 106:
Page 110:
Page 114:
Page 118:
54 P-J. Lou, W-L. Hsu, Y-C. Chien e
Page 122:
Page 126:
Page 130:
Page 134:
Page 138:
Page 142:
66 K. S. Lohobviously surmise that
Page 146:
68 K. S. LohTable 6.2. Causal assoc
Page 152:
Pathology of Nasopharyngeal Carcino
Page 156:
Page 160:
Page 164:
Page 168:
Page 172:
Imaging in the Diagnosis and Stagin
Page 176:
Page 180:
Page 184:
Page 188:
Page 192:
Page 196:
Page 200:
96 J-C. Linon the outcome. The aim
Page 204:
98 J-C. LinTable 9.1. Summary of pr
Page 208:
100 J-C. LinTable 9.2. Summary of p
Page 212:
102 J-C. Lintumor volume was found
Page 216:
104 J-C. Lin(Neel et al. 1984a; Nee
Page 220:
106 J-C. Linradiotherapy became hig
Page 224:
108 J-C. Linsis. However, the false
Page 228:
Page 232:
112 J-C. LinTable 9.6. Summary of o
Page 236:
114 J-C. LinTable 9.7. Summary of t
Page 240:
Page 244:
118 J-C. Lincontaining 59 NPC patie
Page 248:
120 J-C. Linpatients of three nonke
Page 252:
122 J-C. Linfactor for metastasis-f
Page 256:
124 J-C. LinTable 9.9. Prognostic i
Page 260:
126 J-C. LinTable 9.10. Prognostic
Page 264:
128 J-C. Linthat it may trigger the
Page 268:
130 J-C. LinChen Y, Liu MZ, Liang S
Page 272:
132 J-C. LinHwang CF, Cho CL, Huang
Page 276:
134 J-C. LinMa BB, Leung SF, Hui EP
Page 280:
136 J-C. LinWang CC (1991) Improved
Page 284:
138 R. Ove, R. R. Allison, and J. J
Page 288:
Page 292:
Page 296:
Page 300:
Page 304:
Drug Therapy for Nasopharyngeal Car
Page 308:
Page 312:
Page 316:
Page 320:
Page 324:
Page 328:
The Intergroup 0099 Trial for Nasop
Page 332:
Page 336:
Page 340:
Concurrent Chemotherapy-Enhanced Ra
Page 344:
Page 348:
Page 352:
Page 356:
Page 360:
Page 364:
Page 368:
Page 372:
184 A. W. M. Lee14.2Nonrandomized S
Page 376:
186 A. W. M. Leescheduled. With a m
Page 380:
188 A. W. M. LeeTable 14.2. Phase I
Page 384:
190 A. W. M. LeeLR-FFR was slightly
Page 388:
192 A. W. M. LeeLee AW, Lau WH, Tun
Page 392:
194 B. C. Gohthe similarly favorabl
Page 396:
196 B. C. GohLi Zhang, Chong Zhao,
Page 400:
198 L. Kong, J. J. Lu, and N. Leean
Page 404:
200 L. Kong, J. J. Lu, and N. Leetr
Page 408:
202 L. Kong, J. J. Lu, and N. LeeFi
Page 412:
Page 416:
Page 420:
208 L. Kong, J. J. Lu, and N. LeeTa
Page 424:
210 L. Kong, J. J. Lu, and N. Leevo
Page 428:
Selection and Delineation of Target
Page 432:
Page 436:
Page 440:
Page 444:
Page 448:
Page 452:
Page 456:
Page 460:
Page 464:
Page 468:
Post-treatment Follow-Up of Patient
Page 472:
Page 476:
Page 480:
Page 484:
Management of Patients with Failure
Page 488:
Page 492:
Page 496:
Page 500:
Page 504:
Page 508:
254 W. I. Weimanagement of recurren
Page 512:
256 W. I. Weicisplatin and 5-fluoro
Page 516:
258 W. I. WeiTumourAdipose tissueFi
Page 520:
260 W. I. Weiradiation dose is high
Page 524:
262 W. I. Weiartery has to be prote
Page 528:
264 W. I. WeiFig. 20.21. The mucope
Page 532:
Systemic Treatment for Incurable Re
Page 536:
Page 540:
Page 544:
Page 548:
Long-Term Complications in the Trea
Page 552:
Long-Term Complication in the Treat
Page 556:
Page 560:
Page 564:
Page 568:
Page 572:
Page 576:
Page 580:
Page 584:
Page 588:
Nasopharyngeal Cancer in Pediatric
Page 592:
Page 596:
Page 600:
Page 604:
Page 608:
Page 612: Nasopharyngeal Cancer in Pediatric
Page 616: Staging of Nasopharyngeal Carcinoma
Page 620: Staging of Nasopharyngeal carcinoma
Page 644: Subject IndexAAcoustic neuritis, 28
Page 648: Subject Index 325FFamilial aggregat
Page 652: Subject Index 327Neck dissection- m
Page 656: Subject Index 329Thyroid hormone re
Page 660: 332 List of ContributorsJay S. Coop
Page 666: Medical RadiologyDiagnostic Imaging
Page 670: Medical RadiologyDiagnostic Imaging
show all

Familial Nasopharyngeal Carcinoma 6

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?